COVID-19-induced psychosis: new challenges for early career psychiatrists
- Authors: Maiti T.1, Essam L.2, Orsolini L.3,4, Ramalho R.5, El Halabi S.6, Nguyen V.7, Gürcan A.8, Jakhar J.9, Pinto da Costa M.10,11,12, Ojeahere M.I.13, Shoib S.14, Fedotov I.A.15
-
Affiliations:
- JIMSH
- GSMHAT
- Hertfordshire University
- Polytechnic University of Marche
- University of Auckland
- Westchester Medical Center
- Baylor College of Medicine
- Koru Ankara Hospital
- Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
- Institute of Psychiatry, Psychology & Neuroscience, King’s College London
- Institute of Biomedical Sciences Abel Salazar
- University of Porto
- Jos University Teaching Hospital
- Jawahar Lal Nehru Memorial Hospital
- Ryazan State Medical University
- Issue: Vol 29, No 2 (2021)
- Pages: 325-331
- Section: Reviews
- URL: https://journals.rcsi.science/pavlovj/article/view/72035
- DOI: https://doi.org/10.17816/PAVLOVJ72035
- ID: 72035
Cite item
Abstract
The COVID-19 pandemic and its impact on mental health has remained immense and global in all senses. Various types of induced psychiatric disorders, both new episodes and exacerbation of the preexisiting ones has been reported - starting from adjustment disorder to full psychotic illnesses.
Various clinical symptoms, including systematized delusions, affective symptoms and self harm ideas has been mentioned needing upto prolonged admission and in patient care. Various etiopathogenetic models, incluing direct neural infection to cytokine storms or unmasking of the hidden vulnerabilities has been proposed however this needs further research. Traditional antipsychotic pharmacological agents has been proven to work well though special attention to pharmacological interactions is needed with caution for co morbid conditions and chance of side effects.
We collaborated in worldwide Task Force of early career psychiatrists and prepared the definition of our point of view.
Full Text
##article.viewOnOriginalSite##About the authors
Tanay Maiti
JIMSH
Author for correspondence.
Email: drtanaymaiti@gmail.com
ORCID iD: 0000-0001-8880-8773
MD, DPM, DNB, MNAMS, Assistant Professor
India, KolkataLamiaà Essam
GSMHAT
Email: drtanaymaiti@gmail.com
ORCID iD: 0000-0002-5657-2388
MD, Dr.Sci.(Med.), Junior Neuropsychiatry Resident
Egypt, CairoLaura Orsolini
Hertfordshire University; Polytechnic University of Marche
Email: drtanaymaiti@gmail.com
MB ChB (Hons), MScCrim, PGCert (Forensic PSY), Psychiatrist and Clinical Researcher, Department of Clinical Neurosciences/DIMSC, School of Medicine
United Kingdom, Hatfield; AnconaRodrigo Ramalho
University of Auckland
Email: drtanaymaiti@gmail.com
ORCID iD: 0000-0002-2372-6854
MD, Dr.Sci.(Med.), Psychiatrist, Department of Social and Community Health, School of Population Health
New Zealand, AucklandSarah El Halabi
Westchester Medical Center
Email: drtanaymaiti@gmail.com
ORCID iD: 0000-0003-2012-6041
MD, Dr.Sci.(Med.), Psychiatrist, Psychiatry Department
United States, New YorkVinh-Son Nguyen
Baylor College of Medicine
Email: drtanaymaiti@gmail.com
ORCID iD: 0000-0003-4340-995X
MD, Dr.Sci.(Med.), Resident Physician, Menninger Department of Psychiatry and Behavioral Sciences
United States, HoustonAhmet Gürcan
Koru Ankara Hospital
Email: drtanaymaiti@gmail.com
MD, Dr.Sci.(Med.), Psychiatrists, Department of Psychiatry
Turkey, AnkaraJitender Jakhar
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
Email: drtanaymaiti@gmail.com
ORCID iD: 0000-0003-1655-7930
MD, Dr.Sci.(Med.), Senior resident, Department of psychiatry
India, DelphiMariana Pinto da Costa
Institute of Psychiatry, Psychology & Neuroscience, King’s College London; Institute of Biomedical Sciences Abel Salazar; University of Porto
Email: drtanaymaiti@gmail.com
ORCID iD: 0000-0002-5966-5723
MD, Dr.Sci.(Med.), Researcher
United Kingdom, London; PortoMargaret I. Ojeahere
Jos University Teaching Hospital
Email: drtanaymaiti@gmail.com
MBBS, FWACP, Psychiatrist and Clinical researcher, Department of Psychiatry
Nigeria, Jos, Plateau StateSheikh Shoib
Jawahar Lal Nehru Memorial Hospital
Email: drtanaymaiti@gmail.com
MD, Dr.Sci.(Med.), Department of Psychiatry
India, Srinagar, KashmirIliya A. Fedotov
Ryazan State Medical University
Email: drtanaymaiti@gmail.com
ORCID iD: 0000-0002-2791-7180
MD, Cand.Sci.(Med.), Associate Professor of Psychiatry Department
Russian Federation, RyazanReferences
- Dickerson F, Jones-Brando L, Ford G, et al. Schizophrenia is Associated With an Aberrant Immune Response to Epstein–Barr Virus. Schizophrenia Bulletin. 2019;45(5):1112-9. doi: 10.1093/schbul/sby164
- Watson CJ, Thomas RH, Solomon T, et al. COVID-19 and psychosis risk: Real or delusional concern? Neuroscience Letters. 2021;741:135491. doi: 10.1016/j.neulet.2020.135491
- Netland J, Meyerholz DK, Moore S, et al. Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2. Journal of Virology. 2008;82(15):7264-75. doi: 10.1128/jvi.00737-08
- Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. International Journal of Infectious Diseases. 2020;94:55-8. doi: 10.1016/j.ijid.2020.03.062
- Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. International Journal of Infectious Diseases. 2020;96:467-74. doi: 10.1016/j.ijid.2020.05.055
- Miller BJ, Gassama B, Sebastian D, et al. Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects. Biological Psychiatry. 2013;73(10):993-9. doi: 10.1016/j.biopsych.2012.09.007
- Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020;395(10229):1033-4. doi: 10.1016/s0140-6736(20)30628-0
- Desforges M, Le Coupanec A, Dubeau Ph, et al. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses. 2019;12(1):14. doi: 10.3390/v12010014
- Gable M, Depry D. Sustained Corticosteroid-Induced Mania and Psychosis Despite Cessation: A Case Study and Brief Literature Review. Journal of Clinical Case Reports. 2015;5(6):1000546. doi: 10.4172/2165-7920.1000546
- Shanbour A, Khalid Z, Fana M. Psychosis and Infodemic Isolation Resulting in First Inpatient Hospitalization During the COVID-19 Pandemic A Case Series. The Primary Care Companion for CNS Disorders. 2020;22(3):20102649. doi: 10.4088/pcc.20102649
- Chandra PS, Shiva L, Nagendrappa S, et al. COVID 19 related Psychosis as an interface of fears, socio-cultural issues and vulnerability- case report of two women from India. Psychiatry Research. 2020;290:113136. doi: 10.1016/j.psychres.2020.113136
- Huarcaya-Victoria J, Herrera D, Castillo C. Psychosis in a patient with anxiety related to COVID-19: A case report. Psychiatry Research. 2020;289:113052. doi: 10.1016/j.psychres.2020.113052
- Rentero D, Juanes A, Losada C, et al. New-onset psychosis in COVID-19 pandemic: a case series in Madrid. Psychiatry Research. 2020;290:113097. doi: 10.1016/j.psychres.2020.113097
- Valdés-Florido MJ, López-Díaz Á, Palermo-Zeballos FJ, et al. Reactive psychoses in the context of the COVID-19 pandemic: Clinical perspectives from a case series. Revista de Psiquiatría y Salud Mental (English Edition). 2020;13(2):90-4. doi: 10.1016/j.rpsmen.2020.07.004
- Brown E, Gray R, Lo Monaco S, et al. The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research. Schizophrenia Research. 2020;222:79-87. doi: 10.1016/j.schres.2020.05.005
- Alba L, Coll C, Sáez S, et al. New-onset psychosis: A case report of brief psychosis related to COVID-19 infection. Psychiatry Research. 2021;301:113975. doi: 10.1016/j.psychres.2021.113975
- Ferrando S, Klepacz L, Lynch S, et al. COVID-19 Psychosis: A Potential New Neuropsychiatric Condition Triggered by Novel Coronavirus Infection and the Inflammatory Response? Psychosomatics. 2020;61(5):551-5. doi: 10.1016/j.psym.2020.05.012
- Parra A, Juanes A, Losada C, et al. Psychotic symptoms in COVID-19 patients. A retrospective descriptive study. Psychiatry Research. 2020;291:113254. doi: 10.1016/j.psychres.2020.113254
- Tariku M, Hajure M. Available Evidence and Ongoing Hypothesis on Corona Virus (COVID-19) and Psychosis: Is Corona Virus and Psychosis Related? A Narrative Review. Psychology Research and Behavior Management. 2020;13:701-4. doi: 10.2147/prbm.s264235
- Nakamura ZV, Nash RP, Laughon SL, et al. Neuropsychiatric Complications of COVID-19. Current Psychiatry Reports. 2021;23(5):5. doi: 10.1007/s11920-021-01237-9
- Parker C, Slan A, Shalev D, et al. Abrupt Late-onset Psychosis as a Presentation of Coronavirus 2019 Disease (COVID-19). Journal of Psychiatric Practice. 2021;27(2):131-6. doi: 10.1097/pra.0000000000000533
- Smith CM, Komisar JR, Mourad A, et al. COVID-19-associated brief psychotic disorder. BMJ Case Reports. 2020;13(8):e236940. doi: 10.1136/bcr-2020-236940
- Correa-Palacio A, Hernandez-Huerta D, Gómez-Arnau J, et al. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report. Psychiatry Research. 2020;290:113115. doi: 10.1016/j.psychres.2020.113115
- Siskind D, Honer W, Clark S, et al. Consensus statement on the use of clozapine during the COVID-19 pandemic. Journal of Psychiatry and Neuroscience. 2020;45(3):222-3. doi: 10.1503/jpn.200061
- Ennis L, Rose D, Denis M, et al. Can't surf, won't surf: The digital divide in mental health. Journal of Mental Health. 2012;21(4):395-403. doi: 10.3109/09638237.2012.689437
- Kozloff N, Mulsant B, Stergiopoulos V, et al. The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders. Schizophrenia Bulletin. 2020;46(4):752-7. doi: 10.1093/schbul/sbaa051
Supplementary files
